Palisade Bio, Inc. Common Stock (PALI) is a publicly traded Healthcare sector company. As of October 20, 2026, PALI trades at $1.44 with a market cap of $245.72M and a P/E ratio of -4.92. PALI moved +5.60% today. Year to date, PALI is -46.40%; over the trailing twelve months it is -22.99%. Its 52-week range spans $0.53 to $2.86. Analyst consensus is strong buy with an average price target of $10.17. Rallies surfaces PALI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for PALI shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $1.44 |
| Market Cap | $245.72M |
| P/E Ratio | -4.92 |
| EPS | $-0.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.86 |
| 52-Week Low | $0.53 |
| Volume | 346.41K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-16.78M |
| Gross Margin | 0.00% |
6 analysts cover PALI: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.17.